Characteristic | ZelanteDVT Group (n = 17) | Solent Group (n = 23) |
---|---|---|
Age, years, mean ± SD | 55.4 ± 21.5 | 60.4 ± 15.4 |
Female, sex, n (%) | 10 (58.8) | 16 (69.6) |
Onset of Symptoms at Presentation, n (%) | ||
≤ 7 days | 11 (64.7) | 16 (69.6) |
≥ 7 days and ≤ 14 days | 6 (35.3) | 7 (30.4) |
Thrombus Segment | ||
Isolated iliofemoral DVT | 11 (64.7) | 15 (65.2) |
With popliteal/calf DVT | 6 (35.3) | 8 (34.8) |
Thrombus Limbs | ||
Left | 9 (52.9) | 16 (69.6) |
Right | 8 (47.1) | 7 (30.4) |
Bilateral | 0 (0) | 0 (0) |
Risk Factors, n, (%) | ||
Major surgery history | 3 (17.6) | 5 (21.7) |
Immobilization | 2 (11.8) | 3 (13.0) |
Hospitalization | 2 (11.8) | 4 (17.4) |
Recent trauma | 4 (23.5) | 3 (13.0) |
May–Thurner syndrome | 1 (5.9) | 4 (17.4) |
Childbirth | 1 (5.9) | 1 (4.3) |
Malignant disease history | 1 (5.9) | 3 (13.0) |
Autoimmune diseases | 1 (5.9) | 2 (8.7) |
Previous DVT or PE | 4 (23.5) | 3 (13.0) |
Family history of venous thromboembolism | 1 (5.9) | 2 (8.7) |
Unknown factors | 4 (23.5) | 4 (17.4) |